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This paper provides an ex-ante economic analysis, comparing six alternative control strategies 
for the eradication of   Bluetongue virus 8 against five incursion scenarios in cattle and sheep 
populations. The economic analysis assumes a common baseline unavoidable cost of public 
and private measures that together contribute to prevention of incursion of BTV8 into 
Scotland. These costs continue over the five year horizon of this analysis regardless of 
whether a BTV8 epidemic ensues in Scotland and their total present value was found to be 
approximately £141m over the 5year period. The benefit of this investment is the costs of a 
BTV8 outbreak avoided; which depends on the time, location and nature of the incursion, on 
the control strategies adopted to counter each incursion, on the persistence of the incursion 
and on the opportunities to mitigate the damage. Specific variations in all these aspects were 
explored.  The benefit-cost ratios were ranked within each incursion scenario to evaluate the 
efficiency of control outlays.  Although the economic model found that benefit-cost ratios 
were greater than 1 for all interventions strategies examined, the control strategy option with 
100% vaccination and protection zone set at Scottish Borders were economically preferable. 
This implies that if avoided this control option would deliver the greatest benefit from 
investment in baseline prevention costs. However, in terms of outbreak losses, this 
vaccination strategy was always most costly.  On the other hand, the control strategy with 
50% vaccination and all Scotland as a protection zone often provides the lowest benefits in all 
control options examined. 
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Bluetongue virus (BTV) has spread around the world covering much of the Americas, Africa, 
southern Asia and northern Australia, and during the recent past has extended its range 
northwards into Europe. The reasons for this last expansion are linked to recent extensions in 
the distribution of its major Old World vector, Culicoides imicola, to the involvement of 
novel Culicoides vectors and to on-going climate change (Purse et al. 2005). BTV outbreaks 
can have severe economic impact on the livestock industry of a country.  In 2007, BTV 
outbreaks in France and the Netherlands were estimated to cost $1.4 billion and $85 million 
respectively (Tabachnick et al. 2008).  
 
The rapid spread of BTV across several European countries, including the southern part of the 
United Kingdom and countries as far north as Sweden, has increased the likelihood that the 
virus will also spread into Scotland. There are significant uncertainties about many aspects of 
the disease including a full understanding of how both the UK livestock (mainly sheep and 
cattle) and the midge populations will respond to BTV and the effectiveness of existing 
disease control measures. Such control measures include vector control, vaccination and 
livestock movement restrictions combined with surveillance for early detection (Defra, 2007). 
  Despite these gaps in knowledge an ex ante assessment of control strategies has to be drawn 
up as a basic prelude to an appraisal of likely control policies.   
 
Because of the public good nature of disease surveillance and control, requisite investments 
are unlikely to be undertaken privately. Even so, fundamental uncertainties related to 
stochastic disease outbreaks make surveillance and control policies relatively challenging to 
design and implement. However, decisions have to be taken in the short term to halt, slow 
down or manage the spread of BTV in Scotland. This requirement became more urgent in 
Autumn 2007 when BTV serotype 8 (BTV8) started spreading in England (Tabachnick et al. 
2008). This work is part of a study commissioned by Scottish Government (SG) in January 
2008 to inform development of policy in response to the specific threat of BTV8 incursion 
into Scotland in 2008/9.  A fundamental economic question concerns the level of surveillance 
investment (cost) that is warranted relative to the likely return that is anticipated in terms of 
avoided outbreak damages (benefit).   As with other public investments for disease control 
(human or animal) society only requires to outlay resources up to the notional point where the 
last (or marginal) cost delivers an equal unit of benefit.    This cost benefit perspective can be 
a compelling part of the evidence base for managing disease and developing the associated 
policy and legislation.  
 
This paper considers the economic impact of BTV8 and undertakes an economic appraisal of 
options to prevent and manage BTV outbreak in Scotland. Recent studies of potential impacts 
of BTV (see DEFRA, 2007; Hoogedam, 2007) have not addressed either the detailed costs 
involved or the economic consequences of the control strategies. This empirical analysis uses 
an  ex-ante cost-benefit framework to assess the policy response, comparing the costs of 
prevention (benefits) with the costs that would ensue if there were an outbreak of BTV8 in 
Scotland.  
  
2.0       Models and methodology 
In theory the optimal level of investment in surveillance is that level where the marginal costs 
equals the marginal benefits of disease outbreak. In practice establishing this theoretical 
optimum is somewhat complicated, but it can be approximated. However, to do this we have 
to identify all costs of surveillance and also the likely costs of outbreaks.  The former is 
relatively straightforward, but the latter is more complicated because one has to simulate 
counterfactual scenarios that predict the damages from a disease outbreak.  It is the damage 
costs in these scenarios multiplied by the probability of their likely occurrence that gives the 
expected damages. The expected damages are the benefits of actually preventing an outbreak 
occurring.  Figure 1 illustrates costs and benefits of a hypothetical BTV8 control measures that 
maximises net benefits. In the upper panel, costs and benefits are plotted against the vertical 
axis. The probability of disease incursion is represented along the horizontal axis, and ranges 
from Pr (0) at the left and rises to the maximum Pr (max) at the right. The cost of BTV 
control curve represents the baseline surveillance costs against which the benefits will be 
judged. They represent the sum of all ex-ante investments or passive surveillance costs from 
both private and public sectors that will reduce the risk of BTV outbreaks or reduce their 
severity in Scotland. For simplicity it is assumed that to reduce the probability of a BTV 
incursion, the cost would rise at an increasing rate while the benefit curve is linear and 
continuous. 
 
The level of risk corresponding with the highest net benefit is shown by Pr (*) in the lower 
panel. The benefits of lowering risks of a BTV outbreak to this level corresponds to costs C* 
and benefits B* (B*>C*). Notice that the difference between B* and C* is optimum and thus 
corresponds to maximum net benefit NB in the lower panel.  It can be seen that at Pr (*) both 
curves have the same slope, which shows that the marginal benefit and marginal cost of 
disease control are equal. The disease control level that is consistent with Pr (*) would be the 
most efficient measure. 
 
 
Figure 1: Costs and benefits of BTV control at different levels of incursion 
probabilities (Adapted from Hinchy and Fisher, 1991). 
 
It is evident in the upper panel that at probability levels above Pr(*) costs and benefit are 
increasing but costs are rising at a slower rate as compared with benefits. This gives 
increasing net benefits at the margin as the level of risk decreases towards Pr(*). However, at 
risk levels below Pr (*), costs are increasing at higher rates than benefits. This causes 
successive decreases in net benefits at the margin. Thus, control measures not corresponding 
to Pr (*) are not optimal because welfare would not be maximised. 
 
Clearly, the decisions on a control measure that yields optimum social benefits are determined 
by translating epidemiological impacts of BTV into the economics of damage costing. The 
following sections describe how our epidemiological model feeds into the economic 
framework to discern benefits and costs.  
 
2.1       The integrated modelling framework 
The basic framework used in the modelling strategy of BTV8 is set out in Figure 2. Due to 
paucity of data on the relevant biology, the economic and epidemiological modelling approaches used in this paper had to be based on expert derived knowledge about how BTV8 
would most likely behave in Scotland. A multidisciplinary expert panel was formed, 
including BTV and midge experts and disease-control policy makers.  The panel agreed a 
range of feasible BTV8 incursion scenarios and specific control strategies to investigate. Our 
study utilised data already held by different members of the project team but was 
predominantly desk based, applying quantitative methodologies with pre-existing 
epidemiological models.   
 
 
Figure 2: Schematic representation of the modelling framework 
  
The modelling framework consists of two main model components, which are represented by 
the broken line boxes. The epidemiological model was used to simulate the spread of disease 
under selected incursion scenarios and control strategies. The output of the epidemiological 
model provided inputs for a spreadsheet economic model that was used to estimate BTV8 
outbreak costs and benefits. The whole processes of the development of epidemiologic and 
economic models were based on data inputs from relevant literature or from the project data 
providers (e.g. EPIC and RADAR). Where information gaps existed in the literature, data 
inputs based on expert stakeholder were used. Below, the individual model components are 
briefly described. 
  
2.1       Epidemiological Model 
A BTV8 outbreak in Scotland and its spread was assessed using a stochastic, spatial 
epidemiological model describing both the within- and between-farm transmission of BTV. 
Transmission between farms was modelled by a generic transmission kernel, which includes 
both animal and vector movements. Once a farm acquired infection, the within-farm 
dynamics were simulated based on the number of cattle and sheep kept on the farm and local 
temperatures (Gubbins et al. 2008). An affected farm was assumed to be detected if an animal 
died due to BTV8 infection or if overt clinical signs appeared. 
 
Epidemiological parameters for the transmission probability between farms were estimated 
using data on clinically affected holdings in northern Europe in 2006 (Albers et al. 2007; 
EFSA 2007). Parameters for the within-farm dynamics of BTV were derived from the 
published literature, including temperature dependence wherever possible (Gubbins et al. 
2008). Species-specific probabilities for an animal showing overt clinical signs were estimated from OIE reports for 2007 (Szmaragd et al. 2007). Policy parameters represent the 
vaccination strategy that should be implemented, with the vaccine assumed to be 100% 
effective in all animals. The sector parameters were derived from sectoral data such as animal 
movement data, number and distribution of livestock. 
 
For each scenario described above 100 replicates of the epidemiological model were 
simulated with the initial conditions specified according to the incursion scenario. 
Importantly, only a single incursion event was considered. Each replicate was run for two 
years, starting in January of the year in which the incursion occurred. 
2.2       Economic model 
The economic model used for estimating the costs and benefits of BTV8 incursion and 
control strategies in Scotland has been used previously for calculating the direct costs 
associated with endemic diseases of livestock in Great Britain (Bennett et al., 1999).  This 
spreadsheet model was based on the risk of livestock contracting a disease and associated 
costs of prevention, treatment and reduced performance. Menzies et al. (2002) applied this 
methodology to estimate the direct costs of cataracts in farmed Norwegian salmon.   A 
spreadsheet model similar to that of Bennett et al. (1999) and Menzies et al. (2002) was 
adapted and extended by Moran and Fofana (2007) to account for the cost and benefits of fish 
disease incursion and control in the UK. A similar spreadsheet model to that developed by 
Moran and Fofana (2007) was applied here to estimate the costs and benefits of BTV8 
outbreaks and control strategies in Scotland.  
 
The costs of presence and control of BTV8 were generally categorised into direct and indirect 
costs in the spreadsheet model. Direct costs are the sum of the production losses (direct and 
consequential
[1]) and the costs of disease control. Indirect costs are costs that results from 
price effects due to the disruption in markets (Berentsen et al., 1992a). These costs are 
associated with revenue forgone through loss of markets along the value chain of livestock 
and livestock products. Bennett (2003) defined direct disease cost (C) by the relation (L + R) 
+ T + P where L denotes the value of the loss in expected output due to the presence of a 
disease, R the increase in expenditures on non-veterinary resources due to a disease (farm 
labour, movement restrictions etc.), T the cost of inputs used to treat disease and P is the cost 
of disease prevention measures. While Bennett (2003) limited P to prophylactic measures to 
prevent infection occurring, we extended P to cover public disease surveillance costs. 
 
Otte and Chilonda (2000) defined the total cost of disease as a sum of direct and indirect 
production losses. Bennett et al. (1999) model accounts for direct costs but did not include 
indirect cost of disease.   Therefore, the Bennett (2003) model was modified to account for 
indirect cost as defined by adding another variable thus: C = (L + R) + T + P + M, where all 
variables are as previously defined; and M depicts indirect costs which represent the revenue 
forgone through loss of markets along the value chain of livestock and products. It was not 
possible to account for all cost items that should be included in M due to the methodological 
difficulties and constraints of this type of analysis and lack of the extensive data requirements. 
The indirect costs included are the business disruption costs at the retail level due to consumer 
responses and the loss of live animal export revenue due to disease outbreak. There are 
potentially other losses that would occur along the value chain but to avoid the danger of 
double counting costs, only potential losses by the final consumer of UK meat and animal 
products were included. That is the local final consumers and exports that represent external 
final consumers.  
 
Direct and indirect costs were further classified into baseline and avoided  costs. The 
evaluation of policies using cost-benefit analysis (CBA) requires the identification of a 
                                                 
[1]  Consequential on-farm losses include losses due to the fall in stock numbers, restrictions of 
movement when zoning restrictions are put in place and due to the loss in animal value. 
 baseline cost against which the costs and benefits of alternative BTV control options are 
evaluated.  In this study, strict time frame, financial constraint and data difficulties limit the 
questions that can be asked with respect to changes in the level of surveillance (baseline 
costs). Instead, we proposed a simplified analysis that adopts a counterfactual of no 
surveillance versus the current level of combined public and private surveillance.   We 
assumed that outbreaks incur costs and that the outbreak cost with no surveillance is greater 
than when surveillance is in place. It therefore makes sense to have some level of surveillance 
but the optimal level is unknown.  Consequently, it becomes pertinent to ask how speculative 
outbreak costs compare to the current combined public and private costs of surveillance. 
Assuming that the current level of spending is in some sense suboptimal, we therefore analyse 
whether it is disproportionate relative to expected damage.   
 
In economic terms, an avoided cost from an action is a benefit of that action. In the case of 
animal disease, the benefits of measures to prevent or reduce the deleterious effects of disease 
on animals include avoiding costs from the effects of disease, which would otherwise have 
occurred (Malcolm 2003). The benefits of avoiding BTV8 incursion in Scotland include both 
the output losses and control costs (e.g. vaccination costs and movement restrictions) of 
dealing with an incursion. Comparing baseline cost with avoided cost help provide answers to 
the question of optimal surveillance. 
 
Two levels of BTV8 outbreak persistence and two policy options for licensing of the 
movement of livestock to slaughter were analysed. BTV outbreak persistence assumes that 
the disease will persist in year 3 – 5 at year 2 levels and the other disease persistence option 
assumes that BTV will decline in years 3 – 5.  In the case of licensing, we analysed the policy 
options of securing license to move livestock to slaughter or not. 
 
 
3.0       Scenarios, data and assumptions underlying the model 
Scenarios   
We explored the most likely distribution of the disease given Scotland’s agricultural systems, 
unique landscape and climate. We engaged with SG officials and with livestock industry 
representatives to help inform decision making and prioritisation of disease incursion 
scenarios and control options should BTV 8 spread to Scotland. Three main routes for 
potential incursions were identified and a number of approaches were used to determine 
which of these potential routes posed the greatest level of risk. 
o  Wind-borne dispersal of vectors from south-east England, Northern Ireland or 
continental Europe: The risk of incursion via wind-borne midges was assessed using ten 
years worth (1998-2007) of data on wind speed and direction and temperature. These 
were used to determine the frequency of winds suitable for carrying vectors from 
potentially infected areas to Scotland. 
o  Import of infected animals: The risk of introduction via the import of infected animals 
was examined using movement data for 2006 to provide the number of movements to 
each Scottish county by month. 
o  Northwards spread of BTV from south-east England: The risk of northwards spread was 
investigated using a model for the transmission of BTV between farms. This was used to 
predict if and when BTV8 is likely to arrive in Scotland, following expansion from the 
current infected area in south-east England, assuming that only minimal control measures 
were applied. Analysis of climatological data (as in (i) above) was also used to assess the 
risk of incursion if disease foci were to arise near the Scottish border. 
More detail on the risk of incursion was added to the analyses by using the relationship 
between temperature and the extrinsic incubation period (EIP) to predict when and where 
vectors are likely to pose a transmission risk. This was done by linking an accumulated degree-hour model for the completion of the EIP with temperature data for Scotland. 
Following this exercise, five hypothetical incursion scenarios were thus drawn up: 
(a)  South-April 09 Midge (SA09M1): northwards spread of BTV from England arriving 
in April 2009;   
(b)  South-July 08 Midge (SJ08M2): northwards spread of BTV from England arriving in 
July 2008;  
(c)  South-September 08 Midge (SS08M3): northwards spread of BTV from England 
arriving in September 2008;  
(d)  Animal Import April 09 (AI09A 4): import of infected animals in April 2009;  and  
(e)  Animal Import September 08 (AI08S5): import of infected animals in September 
2008. 
 
A wide combination of control strategies can be put in place to reduce the incidence and 
effects of the aforementioned BTV8 incursions. The expert panel selected a range that 
reflected their judgement of the broad classes of alternative options facing SG at the time of 
the study. This included a counterfactual (C1) and five control options C2 to C6. Except for 
C5, all control options were hypothetically applied to all incursion scenarios. Table 1 shows 
the 26 combinations of control strategies and incursion scenarios evaluated; where an element 
Cij in the matrix represents the i
th control strategy applied to j
th incursion scenario.  
 
Table 1: BTV8 Incursion scenarios and control options matrix  
  Incursion Scenario(j) 
Control  Strategies (i)  SA09M1  SJ08M2  SS08M3  AI09A 4  AI08S5  
C1: No vaccination  or 
Counterfactual  C11 C 12 C 13 C 14 C 15 
C2: Control zone options: 
 Border PZ - 100% farms 
vaccinated 
C21 C 22 C 23 C 24 C 25 
C3: PZ to Highland line – 
80% farms vaccinated   C31 C 32 C 33 C 34 C 35 
C4: PZ all Scotland - 50% 
farms vaccinated   C41 C 42 C 43 C 44 C 45 
C5: 100km PZ around 
incursion above the Highland 
line - 80% farms vaccinated 
… … … …  C55 
C6: PZ all Scotland  with 
80% farms vaccinated  C61 C 62 C 63 C 64 C 65 
 
The international acceptance of the concept of zoning in response to an outbreak through the 
OIE code on zoning and regionalisation (OIE, 2003b) implies that if an outbreak of BTV is 
successfully contained within a quarantined area, exports of livestock and products from 
elsewhere in the country may not be affected.  Thus it was assumed that zoning regulations 
will apply in the event of an outbreak of BTV8 in Scotland.  The control of an outbreak will 
be based on movement of animals through a Restriction Zone (RZ). On confirmation of a 
BTV8 outbreak, a Control Zone (CZ) of at least 20km radius is placed around the infected 
premises. A Protection Zone (PZ) of at least 100km radius around the infected premises will 
be declared. A PZ is either the Scottish Border, the Highland line, the whole of Scotland or 
100km around an import north of the Highland line (figure 3).  An optional Surveillance Zone 
(SZ) of 50km radius beyond the PZ will also be instituted if there is a need to do so to contain 
an outbreak.  
Figure 3: Definition of PZs to be used for the control scenarios (C2 and C3). 
The inside dashed line indicates the contour of a 20km buffer zone around the England/Scotland 
border, and the second outside dashed line the contour of a 50km buffer zone. Counties indicated in 
grey-crossing lines will be used to define the tight PZ for vaccination in scenario C2, whereas the grey-
filled counties plus the counties with grey-crossing lines pattern will represent the counties to be 
included within the South-Highlands-line PZ (scenario C3). The islands of Argyll and Bute are not 
considered with the PZ defined under C3. 
 
Counterfactual (C1) control strategy includes the minimum required control, i.e. movement 
restrictions but no vaccination. Thus there is no effort to reduce the number of susceptible 
animals. It was assumed 100%
[2] and 50% uptake of vaccine in the rest of the PZ for 
strategies C2 and C4 respectively and 80% uptake of vaccine for C3 and C6. Where an 
incursion takes place in April 2009 (i.e. incursions SA09M1 and AI09A4) vaccination is 
assumed to be administered before incursion (i.e. in January 2009) when animals are likely to 
be more accessible. For the other incursions vaccination takes place after initial detection of 
an outbreak. Control strategy C5 is included to cover the special case of incursion AI08S5 
where vaccine location depends on place of incursion. 
                                                
 
In the case of incursion AI08S5 (import in September 2008) the PZ would be established 
depending on where the incursion occurs. If the incursion occurs within the border PZ, then 
C2 control strategy is to be used. If the incursion occurs south of the Highland line (figure 3), 
control strategy C3 is put in place, and if the incursion takes place north of the Highland line, 
then a 100km PZ is established around the holding where the incursion occurred, and 80% 
uptake is assumed within this PZ. In line with the other vaccination options, a 20km CZ will 
also be established around the incursion with 100% vaccination. Therefore the fifth control 
strategy C5 will complement options C2 and C3, in the case of a northern import.  
 
 
[2] 100% vaccination within a temporary CZ is assumed compulsory. The different levels of vaccine uptake assumed reflected alternative SG policy options. Where 
uptake was 50% (C4) this reflected a voluntary vaccination scheme. Higher levels of uptake 
were thought likely to need a compulsory vaccination programme. For all incursion scenarios 
we assumed that vaccination is efficient at controlling the spread of BTV8, by reducing the 
probability of transmission between the midge vector and the ruminant host. In the absence of 
data for the efficacy of the vaccine to be used, we assumed that it was 100% effective in 
protecting vaccinated animals against BTV8. Cost relating to the uptake of voluntary and 
compulsory vaccination was obtained from SG and included a mail shot to all livestock 
holders in PZ, specialist media (advertising), mail shot to vets, costs related to vet 
administration and certification of animals for export.
[3]  
 
3.1       Assumptions and quantification of costs  
The evaluation of BTV surveillance measures in different outbreak scenarios requires a 
combination of assumptions on economic parameters to derive the costs. As an ex ante 
analysis, the evaluation of costs were based on a set of projections for the production and 
prices of sheep, cattle, sheepmeat, beef, milk, cheese and wool using autoregressive integrated 
moving average (ARIMA) over the period to 2013. ARIMA models were used because of 
their robustness, less data demanding and they have been proved to outperform more 
sophisticated structural models for short-run forecasting potentials (see Stockton and 
Glassman, 1987 and Litterman, 1986). The data on production and prices were obtained from 
various issues of Meat and Livestock Commission (MLC) publications and SG. 
 
3.1.1    Surveillance and control costs 
Quantification of surveillance and control cost estimates are substantially more certain than 
some of the outbreak cost elements (Moran and Fofana, 2007). We identified surveillance 
costs of BTV8 from those borne by producers (private) and those incurred by the public 
sector.
[4]  The surveillance costs presented in this paper are generic costs and not specific to 
any disease. They represent the various roles carried out by SG agencies in the surveillance 
and control of all animal diseases. Though there is a passive element in disease surveillance 
and control,   it was viewed as prudent to scale down public sector surveillance costs to avoid 
the dangers of high overestimates. But by what value to scale these costs down is a matter for 
conjecture. In consultation with expert stakeholders, we assumed that BTV8 surveillance 
expenditure in the public sector will be in the order of 2% and 0.5% of total public sector 
surveillance costs for sheep and cattle respectively. Animal disease surveillance cost data 
were projected from the data obtained from SG. The data set was obtained in aggregated form 
and recorded in financial year. To make the cost data compatible with the rest of the data, we 
took the financial year data to represent calendar years. In the private sector we follow Moran 
and Fofana (2007) that farmers’ interest is to grow healthy stock that would improve their 
income rather than worry about a specific disease.  Therefore we assumed that veterinary 
treatment of livestock is good husbandry practice and it is meant to keep any form of disease 
at bay.  Consequently, we took all expenditure in the private sector that is geared towards 
keeping a healthy stock prior to the outbreak of BTV8 as private sector surveillance 
expenditure. 
 
3.1.2    Reduced milk yield, weight loss, wool loss and reproductive disorders 
The expected costs associated with morbidity of sick animals due to BTV8 include weight 
loss and reduced milk yield due to the inability of animals to feed for several days 
(Tabachnick et al. 2008, Osburn 1994). Such weight loss may influence milk production in 
dairy livestock. We did not attempt to model the impact of weight loss on milk production.  
                                                 
[3] Costs of legislation and random monitoring in the case of compulsory vaccination were not included.  
 
[4] Public sector animal disease surveillance cost data received were recorded in financial years. We 
have taken the financial-year data to represent calendar year for consistency with the rest of the data. Rather we estimated weight loss separate from milk loss. Output data from the 
epidemiological model did not differentiate between dairy cows and other cattle, the expected 
milk losses in dairy cows was therefore estimated by taking the product of: (1) the assumed 
reduction in milk production due to BTV8 (i.e. 5%
[5]); (2) the number of infected cattle (3) 
the probability of dairy cows in the Scottish livestock; (4) the average production of milk per 
dairy cow; and (5) the price of milk per litre.  
 
Weight loss was similarly estimated by taking the product of: (1) the assumed reduction in 
weight for cattle or sheep due to BTV infection; (2) the number of infected animal (cattle and 
sheep); (3) the assumed number of animal that would suffer a weight loss and (5) price of the 
animal per head. There is no guidance in the literature on the degree of weight loss in morbid 
animals.   Therefore we assumed that 9% of infected cattle would show 5-10% weight loss 
and 11% of infected sheep would show 10-15% weight loss
[6]. 
 
In some sheep flocks, no clinical signs are apparent, whereas in other flocks infected by the 
same virus up to 30% may develop signs of disease
[7]. Sheep that recover from BTV8 
infections may render wool fragile and in some cases this can lead to partial or complete 
shedding of wool
[8] which can cause direct economic loss to sheep farmers. In order to 
quantify this loss, we assumed that an average of 2.5 kg of wool is produced per sheep
[9] and 
wool not sheared from 30% of BTV infected sheep. Multiplying the quantity of wool loss by 
price of wool gave the cost of wool loss. 
 
Reproductive disorders associated with BTV include abortion, infertility in bulls and rams 
and malformed lambs or calves. The occurrence of any of these can cause direct economic 
losses to livestock farmers and some times indirect losses due to export restriction or delays in 
recovery of animals that survive. In rams and bulls, BTV infection is known to induce 
infertility, possibly in response to the harmful effect of hyperthermia on spermatogenesis, as 
well as to the effect of micro-vascular lesions in the reproductive tract (Osburn, 1994). There 
is no information about the duration of infertility and probability of recovery and this was not 
incorporated into the spreadsheet model. However, we assumed loss of fertility for beef cows 
to be £2.7/head (Gunn et al. 2004) and loss of fertility for dairy cows to be £2.50/head 
(Santarossa et al. 2004).
[10] In the case of sheep we assume  infertility to cost £0.60/head. This 
was based on expert estimates that BTV8 might double the risk of a morbid ewe being barren, 
that a normal rate of barreners is about 6/100 ewes (Conington te al., 2004), that a barrener 
costs about £17 loss of net revenue (SAC, 2007) and that morbidty rates in BTV8 infected 
flocks is about 0.6 (Defra, 2007).  
 
3.1.3    Livestock mortality and carcass disposal cost 
We assumed that during an outbreak of BTV8, the disposal options will be limited to 
incineration or rendering as the only legal methods of disposal of diseased animal 
carcasses.
[11]  The disposal of dead animal will be done by appropriate animal disposal 
contractors such that it fulfils environmental and animal by-products legislations. Carcase 
disposal cost was computed by taking the product of the number of animal casualties due to 
BTV8. The costs of incineration of animal carcasses used were £75/head for cattle or 
                                                 
[5] Johannes Winkelman, personal communication (2008). 
[6] A lower and an upper band of weight loss was assumed for sheep and cattle based on personal 
communications with experts in various EU countries. 
[7] http://www.sgm.ac.uk/news/hot_topics/btv.pdf 
[8] www.vet.uga.edu/vpp/gray_book02/fad/blt.php 
[9] Production of wool per sheep varies considerably from 1.7 kg – 9kg per animal (see Roche, 
J. 1995).  
[10] Note these figures exclude impacts of fertility on production to avoid double counting.  
[11] The only exemptions to the ban in the UK are for remote areas of the Highlands and Islands of 
Scotland (www.allgoats.org.uk/carcase.htm). £20/head for sheep (Defra 2007). We assumed no compensation to farmers for lost or culled 
animals. 
 
3.1.4    Palliative and veterinary costs 
Palliative care is any form of medical care or treatment that concentrates on reducing the 
severity of BTV disease symptoms. The goal is to prevent and relieve suffering in that 
condition. It was assumed that a 600 kg cow would require a dose of (60 ml per 600 kg 
bodyweight)  of    Alamycin la
[12] and Fluxin.
[13]   Since sheep are the most susceptible to 
BTV8, it was assumed that an 80 kg sheep would require doses of Alamycin la and Fluxin for 
five and three days respectively. Costs of extra palliative veterinary care were also included 
by multiplying the number of infected animals by the cost of the recommended dosage of 
Alamycin la and Fluxin for sheep and cattle. 
 
3.1.5    Movement restrictions, labour cost and pre-testing of imported animals 
Crucial to the success of control strategies is the placing of high risk holdings and livestock 
production areas under animal movement restrictions. Effects of animal movement 
restrictions were incorporated into the spreadsheet model. The cost associated with movement 
restriction was modelled in the spreadsheet by costing movement restriction at 5% of the 
value of the animal (Defra, 2007) under each outbreak scenario where zoning regulation 
applies.  
 
There are labour costs associated with disease outbreak which imposes cost on the livestock 
farmer. The value of farm labour costs is difficult to estimate. The value of increased labour 
time by a farm worker will depend on the opportunity cost of the labour time (Bennett 2003) 
and on the extent and severity of the disease out break.  In order to estimate cost in the 
category we assume that the livestock industry will be reliant upon family-based labour to 
supplement farm labour at a cost of £1/hour (Gunn et al., 2004). The extra labour input was 
assumed to be two minutes per morbid sheep and seven minutes per morbid cattle per day as 
indicated by expert opinion.  
 
Pre-testing of imported cattle and sheep is carried out to detect BTV8 which incurs costs. The 
cost related to this was estimated by assuming that 75% of international imports of live 
animals are from BTV affected countries which need testing and 100% of imports of live 
animal from the rest of UK need testing
[14]. Using this assumption the number of livestock 
was multiplied by the price of testing to derive costs.  
 
 3.1.6   Consumer reaction and revenue loss at retail   
Recent evidence suggests that humans are sero-negative towards BTVs (Jun Hu et al. 2008). 
But when an outbreak of BTV8 occurs this might not be recognised by domestic consumers. 
Media coverage of the outbreak alone may be sufficient to dissuade consumers from 
purchasing beef, sheep meat and other related products. The apparent reduction in demand by 
consumers was modelled using relevant estimates of price elasticity of demand. We 
anticipated that a disease outbreak would actually increase prices because of the shortages it 
would cause due to quarantine activities, depopulation and movement restrictions in the 
industry. We modelled the apparent change in demand by beef and sheep meat and consumers 
using relevant estimates of price elasticity of demand.  
 
It was envisaged that a BTV8 outbreak will have an instant impact on consumer demand for 
fresh beef and sheepmeat. This was replicated in the spreadsheet model by assuming 




[14] Based on the international trade statistics of UK.  instantaneous adjustment of consumption of fresh meat products to the news of an outbreak.  
This assumption may not hold for the industry products like cheese and milk as there may be 
some time delays in the change of consumer demand for these products. There may be 
increases in demand for milk and cheese as many consumers will substitute meat and meat 
products in their diets with dairy products such as cheeses due to disease outbreak (OECD 
2002). However, we worked with the normal expectation that a BTV8 outbreak will impact 
consumer confidence in the purchase of milk and cheese albeit at a lower rate as compared 
with fresh meat products. As a result of these influences, we found it necessary to incorporate 
lags in demand change for cheese and milk to mimic consumers’ reaction in the demand of 
these products. The lags were included in the spreadsheet model such that current apparent 
domestic consumption dependent on the previous period’s level of consumption and thus 
accounts for time delays in purchase as news of a BTV8 outbreak spreads. Estimates of 
apparent domestic consumption of animal products were derived by adding domestic 
production to imports and subtracting exports from the resultant. Apparent domestic 
consumption of animal products was needed to simulate the quantities of animal products 
consumed locally when such data can not be accessed from secondary sources. 
 
3.1.7    International trade losses 
Export trade restrictions imposed on animals and livestock products during disease outbreak 
usually have the potential to cause major losses to exporters (Schoenbaum and Disney, 2003). 
The Scottish livestock sector is linked to sectors in the local economy and international trade 
through a network of input purchases and output sales. The reduction of Scottish exports 
caused by BTV8 related international trade restrictions will depend upon the livestock and 
livestock products subject to bans, the duration and the trading regions affected by these bans. 
 
The products which should be subject to export bans are live animal exports and germplasm. 
OIE and EU rules indicate that export bans are not applicable to livestock products such as 
milk and cheese. Data could not be found for Scottish germplasm production and we therefore 
included live animal exports only in our economic model. We used input-output (IO) analysis 
to simulate the effect of an export ban in Scotland.  IO analysis is a technique that has been 
used in several research papers to simulate the economic effects of export ban due to disease 
(e.g. see Mahul and Durand 2000). 
 
The equilibrium between total supply and total demand for each sector can be captured in a 
single set of equations written as  ; where Y is the vector of final demand, A the 
matrix of input-output coefficients, X the vector of outputs.  The final demand equation can 
be manipulated to yield a multiplier as , where    is the Leontief 
inverse matrix that can be used to simulate overall changes in sectoral outputs, such as the 
livestock sector, which result from changes in final demand. Following Mahul and Durand 
(2000) and defining final demand by  where D is the vector of the domestic 
demand, E the vector of exports and M the vector of imports. Therefore, a change in the 
exports, the imports and the domestic demand being unchanged, will affect sectoral output 
through the associated multipliers.  Input-output multipliers obtained from Scottish, Economy 
Statistics - Input-Output Tables 2004 were used to measure the magnitude of the effects that 
export ban have on Scotland.  
 
4.0       Results  
4.1       Spreadsheet cost-benefit analysis
[15] 
In an ex ante CBA it would be ideal to have estimates of the relative probability of the 
incursion scenarios.  The probabilities can be used to compute an overall expected benefit and 
make comparisons between incursion scenarios. Unfortunately given the level of uncertainty 
                                                 
[15] Spreadsheet is available from the authors upon request. involved it was very difficult to derive any quantitative estimates for the probability of each 
incursion scenario as the risks are as yet too poorly understood. Consequently, we confined 
our analysis within each incursion scenarios by ranking of benefit-cost ratios (BCR).   
 
All present-value equivalents are calculated using a social discount rate from the UK Treasury 
Green Book
[16] (3.5%). We considered net present value (NPV) and the BCR investment 
indicators.   In each scenario all benefits are summed and costs subtracted to arrive at an 
estimate of Net Present Value (NPV). The BCR is computed as the sum of discounted annual 
benefits divided by the sum of discounted annual costs. A worthwhile investment in BTV8 
prevention in each scenario should generate sufficient benefits to at least cover the investment 
costs.   This implies that the NPV should be positive and the BCR greater than one. In 
economic terms, the higher the values of NPV and BCR, the more attractive the investment in 
the baseline surveillance/prevention costs of BTV8. Since there are considerable uncertainties 
over assumed probabilities, benefit cost ratios were used to rank interventions in terms of 
economic efficiency. The costs and benefits generated for the diseases from the spreadsheet 
model are summarised in Table 3 for within incursion scenarios.   
 
 
Table 3: Within incursion scenario CBA for average values from the 
epidemiological model 
 
  BTV stay at year 2 values in years 3-5  BTV dies out gradually after year 2 
  Control Options    Control Options 
Scenarios C1  C2  C3 C4  C5  C6          C1 C2 C3 C4 C5  C6 
Sum of discounted cost  
(£m)  140.8 140.8 140.8 140.8 140.8 140.8 140.8 140.8 8
140
        
6 2  
8 4  
9 7  
3 9  
5 1  
7 5  
6 2  
8 4  
9 7  
      
3 9
5 1  
7 5  
9 3
3 7  
8 7  
      
1 9  
                                                
140. 140.8  .8  140.8 
SA09M1 (Midge transmission from south in April 2009) 
No license for move-to-slaughter               
  Sum of discounted benefits  
(£m)  344.5 470.5 426.2 340.7 .. 350.7 334.7 412. 384. 333.6 ..  338.7
  NPV  203.8 329.8 285.5 200.0 .. 209.9 193.9 271. 243. 192.8 ..  197.9
  BCR  2.5 3.3 3.0 2.4 .. 2.49 2.4 2. 2. 2.4 ..  2.4
With license for move-to-slaughter 
  Sum of discounted benefits  
(£m)  335.9 414.9 380.9 340.7 .. 350.7 329.6 379. 356. 333.6 ..  338.7 
  NPV  195.2 274.1 240.1 200.0 .. 209.9 188.8 238. 216. 192.8 ..  197.9 
  BCR  2.4 3.0 2.7 2.4 .. 2.5 2.3 2. 2. 2.4 ..  2.4 
SJ08M2 (Midge transmission from south in July 2008) 
No license for move-to-slaughter        
  Sum of discounted benefits  
(£m)  344.5 470.5 426.2 340.7 .. 350.5 334.7 412. 384. 333.6 ..  338.5 
  NPV  203.8 329.8 285.5 200.0 .. 209.9 193.9 271. 243. 192.8 ..  197.9 
  BCR  2.5 3.3 3.0 2.4 .. 2.5 2.4 2. 2. 2.4 ..  2.4 
With license for move-to-
slaughter                
  Sum of discounted benefits  
(£m) 335.9 414.9 380.9 340.7 .. 350.5  329.6 379. 356. 333.6  ..  338.5 
  NPV  195.2 274.1 240.1 200.0 .. 209.9 188.8 238. 216. 192.8 ..  197.9 
  BCR  2.4 3.0 2.7 2.4 .. 2.49 2.3 2. 2. 2.4 ..  2.4 
SS08M3 (Midge transmission from south in September 2008) 
No license for move-to-slaughter    
  Sum of discounted benefits  
(£m) 359.1 453.6 417.2 349.8 .. 350.5  341.7 398. 375. 337.8  ..  338.5 
  NPV  218.5 313.0 276.6 209.2 .. 209.9 201.1 258. 234. 197.2 ..  197.9 
  BCR  2.6 3.2 3.0 2.5 .. 2.5 2.4 2. 2. 2.4 ..  2.4 
With license for move-to-
slaughter                 
  Sum of discounted benefits   348.4 408.7 376.9 349.8 .. 350.5 335.8 374. 352. 337.8 ..  338.5 
 
[16] http://greenbook.treasury.gov.uk/annex06.htm (£m) 
  NPV  207.8 268.2 236.3 209.2 .. 209.9 195.2 233.6 3  
7 5  
enefits(£m)  . 0 3 5 7 
6 7  
1 0  
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8 7  
  
5 4 8 9 
373
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4 .7 6 6 2.
212. 197.2 ..  197.9 
  BCR  2.5 2.9 2.7 2.5 .. 2.5 2.4 2. 2. 2.4 ..  2.4 
AI09A4 (Animal import April 2009) 
No license for move-to-slaughter        
  Sum of discounted b























  BCR  2.7 3.6 3.5 3.1 .. 3.1 2.5 3. 3. 2.8 ..  2.8 
With license for move-to-
slaughter 
  Sum of di
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(£m) 

























  BCR  2.5 3.1 2.9 2.9 .. 2.8 2.4 2. 2. 2.6 ..  2.6 
AI08S5 (Animal import September 2008) 
No license for move-to-slaughter     
 Sum of discounted benefits (£m) 




238.2 337.5 325.7 293.3 274.2 293.8 204.7 273. 261. 244.2  .4 244.7 
 BCR  2.7 3.4 3.3 3.1 3.0 3.1 2.5 2. 2. 2.7 2.7  2.7 
With license for move-to-
slaughter                 
 Sum of discounted benefits  


























2.6   BCR 
 
In general, total current discounted benefits for all incursions scenario over five years range 
between £330m to £500m. All the scenarios are economically viable with positive net present 
values and BCR greater than one. Whether the disease fades out or not, control option C2 
(Border PZ - 100% vaccinated) or 100% vaccination with a PZ starting at the Scottish 
Borders yields the highest discounted benefit and respectable BCRs within incursion 
scenarios. However, as benefits are defined as total disease losses avoided, this control option 
is associated with the highest disease losses. This means that if this incursion does take place, 
control option C2 (Border PZ - 100% vaccinated) is associated with the highest outbreak 
osts.   c
 
The lowest returns to baseline surveillance costs depend on obtaining a license for movement 
to slaughter. Control option C4 (50% vaccination with Scotland as PZ) for incursions 
SA09M1 (northwards spread of BTV from England arriving in April 2009) and SS08M3 
(northwards spread of BTV from England arriving in September 2008) deliver lowest return 
with no license to slaughter while control option C1 (no vaccination) delivers lowest return 
with license to slaughter. These options have the lowest benefits and therefore relatively low 
BCR. Unlike SA09M1, the lowest return to surveillance cost for SJ08M2 (northwards spread 
of BTV from England arriving in July 2008) depends on the duration of the outbreak or the 
trajectory by which the disease persists after an outbreak as well as on the license position. 
Control option C4 (50% vaccination with Scotland as PZ) for SJ08M2 gives lowest disease 
losses avoided when BTV8 lingers and causes losses equivalent to year 2 levels up to year 5.  
Control option C1 (no vaccination) for incursion SJ08M2 does the same when BTV8 
gradually dies out after year 2 with no licence to slaughter. However, control option C4 (50% 
vaccination with Scotland as PZ) for incursion scenario SJ08M2 remains the best vaccination 
strategy as control option C1 (no vaccination) for incursion scenario SJ08M2 is the no 
accination option.  v
 
 For scenarios AI09A4 (import of infected animals in April 2009) and AI08S5 (import of 
infected animals in September 2008) the lowest returns on investment also appeared to be 
control strategy C1 (no vaccination) for all eradication measures; and seemed not to be 
influenced by either license for move to slaughter or the time trajectory of the disease when an incursion occurs.  The vaccination strategy with the lowest return on investment to prevent 
or to limit the damage caused by BTV8 outbreak is control strategy C4 (50% vaccination with 
Scotland as PZ) for incursion AI09A4 and control strategy C5 for incursion AI08S. 
 
Under the assumptions of the model, control option C2 (Border PZ with 100% vaccination) is 
shown to be a worthwhile investment. That is, this scenario achieves an NPV of at least £195 
million over the 5-year time horizon considered and   respectable BCR of at least 3.0, thereby 
providing returns of £3.0 for every £1 invested for BTV8 outbreak persisting up to year 5.  
Even if BTV8 outbreak fades out gradually, control option C2 yields an NPV of at least £192 
million over the 5-year time horizon and at least a BCR of 2.7 implying providing £2.7 for 
every £1 invested. 
 
5.0       Sensitivity analysis  
The strength of the conclusions drawn from the CBA will obviously depend upon the quality 
of the data and rigour of the analysis. An indication of the robustness of the results is 
provided by conducting sensitivity analyses on the most important parameters to evaluate 
their impact on benefit –cost ratios. Sensitivity analysis was conducted for the following 
parameters: weight loss; milk loss; fertility loss; wool loss; export multipliers for cattle and 
sheep; own-price elasticities for sheep meat, beef and milk. 
 
The sensitivity analysis indicated no change in the CBA ratios for all scenarios when 
parameters for weight loss, milk loss, fertility loss and wool loss were varied. Again, no 
change in the CBA ratios when changes of ±2% were applied for export multipliers for cattle 
and sheep and own-price elasticities for sheep meat, beef and milk. However, the sensitivity 
analysis showed a change of ±1% in the CBA ratios when export multipliers for cattle and 
sheep and own-price elasticities for sheep meat, beef and milk were varied by ±5%. 
 
6.0       Conclusions 
The most likely incursion scenarios are northwards spread from south-east England or import 
of infected animals. The risk of direct incursion of infected vectors from affected areas in 
south-east England or mainland Europe is very low, but not negligible and if a focus of 
infection were to become established in the north of England or Northern Ireland, this would 
pose a distinct incursion risk for Scotland. For this economic assessment, five potential 
incursion scenarios were chosen based on the two most likely routes of incursion.  
 
To see if the benefits of disease being avoided justify the costs of the baseline investment in 
prevention, it is necessary to know the probability of BTV8 incursion into Scotland. 
However, it was not possible to establish this probability. Control options were therefore 
ranked within incursion scenarios. Within each incursion scenario the outbreak losses 
(average discounted benefits) were minimised with either no vaccination (C1) or a PZ across 
all Scotland with 50% vaccine uptake (C4). The ranking depended on incursion scenario, 
disease persistence assumption (declines in years 3 to 5 or persists) and/or mitigation 
opportunity (license to move to slaughter or not). The vaccination strategy that minimised 
outbreak losses was therefore C4. The only exception to this was incursion scenario AI08S5 
(Imported animal, September 2008) where the vaccination strategy associated with the lowest 
outbreak losses was control option C5 (localised vaccination according to where the outbreak 
takes place). 
 
Whether the disease fades out or not, control option C2 (Border PZ - 100% vaccinated) or 
100% vaccination with a PZ starting at the Scottish Borders yields the highest discounted 
benefit and respectable BCRs within incursion scenarios. However, as benefits are defined as 
total disease losses avoided, this control option is associated with the highest disease losses. This means that if this incursion does take place, control option C2 (Border PZ - 100% 
vaccinated) is associated with the highest outbreak costs.  
 
Surprisingly, using the extreme epidemiological outputs made little difference to the 
economic assessment of alternative incursion control options based on average 
epidemiological outcomes. This combined with the results of the sensitivity analysis and the 
consistency between incursion scenarios is reassuring as it suggests that choice of best control 
option will be more robust to the nature and extent of the incursion than might have been 
expected. As decisions about control options usually need to be made in advance of any 
incursion and given the uncertainty that surrounds almost all aspects of this analysis, this is a 
reassuring outcome.  
 
A major outcome from this study was the lessons learnt from the experience of operating as a 
team of scientists, economists, other experts and stakeholders. This issue is epitomised by the 
definition of the CBA framework. This was based from the outset on the assessment of the 
benefits of avoiding future BTV8 outbreak losses through the current (baseline) surveillance 
costs. However, the interests of stakeholders and scientists was in the relative costs of 
alternative vaccination strategies, which would probably need to be ordered and deployed in 
advance of a BTV8 incursion. Vaccination was therefore considered part of disease 
prevention costs needed to avoid other outbreak losses. This focused interest on a comparison 
between outbreak losses with and without vaccination (C1 versus all other strategies). 
However, lack of any estimates of the relative probabilities of BTV8 incursions into Scotland 
conditional on each of the alternative control options investigated frustrated such 
comparisons. Under these circumstances, a clear consistent definition of the CBA framework 
was a key attribute of success. Within each incursion scenario, a control strategy associated 
with lowest outbreak losses emerged but still with cost-benefit ratio >1. In most incursion 
scenarios the same control strategy delivered low or the lowest outbreak losses. This enabled 
useful decision support to be conveyed to SG despite lack of important information and 
differences between control strategies in the proportion of vaccination costs devoted to 
prevention rather than control. 
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